Global Opioids Drug Market Research Report 2026(Status and Outlook)

May 2026 | 142 pages | ID: GCB73DDB3C88EN
Bosson Research

Abstracts

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.

The global Opioids Drug market size was estimated at USD 9694.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of -1.80% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Opioids Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Opioids Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Opioids Drug market.

Global Opioids Drug Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Teva
• Purdue Pharma
• Mallinckrodt
• Amneal Pharma
• Collegium
• J&J
• Endo
• Pfizer
• INSYS
• Mylan
• Hikma
• Egalet

Market Segmentation (by Type)

• Oxycodone
• Hydromorphone
• Codeine
• Fentanyl

Market Segmentation (by Application)

• Pain Relief
• Anesthesia
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Opioids Drug Market

Overview of the regional outlook of the Opioids Drug Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioids Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Opioids Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Opioids Drug
1.2 Key Market Segments
  1.2.1 Opioids Drug Segment by Type
  1.2.2 Opioids Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 OPIOIDS DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Opioids Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Opioids Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 OPIOIDS DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Opioids Drug Product Life Cycle
3.3 Global Opioids Drug Sales by Manufacturers (2020-2025)
3.4 Global Opioids Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Opioids Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Opioids Drug Market Competitive Situation and Trends
  3.8.1 Opioids Drug Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Opioids Drug Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 OPIOIDS DRUG INDUSTRY CHAIN ANALYSIS

4.1 Opioids Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF OPIOIDS DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Opioids Drug Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Opioids Drug Market
5.7 ESG Ratings of Leading Companies

6 OPIOIDS DRUG MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioids Drug Sales Market Share by Type (2020-2025)
6.3 Global Opioids Drug Market Size by Type (2020-2025)
6.4 Global Opioids Drug Price by Type (2020-2025)

7 OPIOIDS DRUG MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioids Drug Market Sales by Application (2020-2025)
7.3 Global Opioids Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Opioids Drug Sales Growth Rate by Application (2020-2025)

8 OPIOIDS DRUG MARKET SALES BY REGION

8.1 Global Opioids Drug Sales by Region
  8.1.1 Global Opioids Drug Sales by Region
  8.1.2 Global Opioids Drug Sales Market Share by Region
8.2 Global Opioids Drug Market Size by Region
  8.2.1 Global Opioids Drug Market Size by Region
  8.2.2 Global Opioids Drug Market Size by Region
8.3 North America
  8.3.1 North America Opioids Drug Sales by Country
  8.3.2 North America Opioids Drug Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Opioids Drug Sales by Country
  8.4.2 Europe Opioids Drug Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Opioids Drug Sales by Region
  8.5.2 Asia Pacific Opioids Drug Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Opioids Drug Sales by Country
  8.6.2 South America Opioids Drug Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Opioids Drug Sales by Region
  8.7.2 Middle East and Africa Opioids Drug Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 OPIOIDS DRUG MARKET PRODUCTION BY REGION

9.1 Global Production of Opioids Drug by Region(2020-2025)
9.2 Global Opioids Drug Revenue Market Share by Region (2020-2025)
9.3 Global Opioids Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Opioids Drug Production
  9.4.1 North America Opioids Drug Production Growth Rate (2020-2025)
  9.4.2 North America Opioids Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Opioids Drug Production
  9.5.1 Europe Opioids Drug Production Growth Rate (2020-2025)
  9.5.2 Europe Opioids Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Opioids Drug Production (2020-2025)
  9.6.1 Japan Opioids Drug Production Growth Rate (2020-2025)
  9.6.2 Japan Opioids Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Opioids Drug Production (2020-2025)
  9.7.1 China Opioids Drug Production Growth Rate (2020-2025)
  9.7.2 China Opioids Drug Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Teva
  10.1.1 Teva Basic Information
  10.1.2 Teva Opioids Drug Product Overview
  10.1.3 Teva Opioids Drug Product Market Performance
  10.1.4 Teva Business Overview
  10.1.5 Teva SWOT Analysis
  10.1.6 Teva Recent Developments
10.2 Purdue Pharma
  10.2.1 Purdue Pharma Basic Information
  10.2.2 Purdue Pharma Opioids Drug Product Overview
  10.2.3 Purdue Pharma Opioids Drug Product Market Performance
  10.2.4 Purdue Pharma Business Overview
  10.2.5 Purdue Pharma SWOT Analysis
  10.2.6 Purdue Pharma Recent Developments
10.3 Mallinckrodt
  10.3.1 Mallinckrodt Basic Information
  10.3.2 Mallinckrodt Opioids Drug Product Overview
  10.3.3 Mallinckrodt Opioids Drug Product Market Performance
  10.3.4 Mallinckrodt Business Overview
  10.3.5 Mallinckrodt SWOT Analysis
  10.3.6 Mallinckrodt Recent Developments
10.4 Amneal Pharma
  10.4.1 Amneal Pharma Basic Information
  10.4.2 Amneal Pharma Opioids Drug Product Overview
  10.4.3 Amneal Pharma Opioids Drug Product Market Performance
  10.4.4 Amneal Pharma Business Overview
  10.4.5 Amneal Pharma Recent Developments
10.5 Collegium
  10.5.1 Collegium Basic Information
  10.5.2 Collegium Opioids Drug Product Overview
  10.5.3 Collegium Opioids Drug Product Market Performance
  10.5.4 Collegium Business Overview
  10.5.5 Collegium Recent Developments
10.6 JandJ
  10.6.1 JandJ Basic Information
  10.6.2 JandJ Opioids Drug Product Overview
  10.6.3 JandJ Opioids Drug Product Market Performance
  10.6.4 JandJ Business Overview
  10.6.5 JandJ Recent Developments
10.7 Endo
  10.7.1 Endo Basic Information
  10.7.2 Endo Opioids Drug Product Overview
  10.7.3 Endo Opioids Drug Product Market Performance
  10.7.4 Endo Business Overview
  10.7.5 Endo Recent Developments
10.8 Pfizer
  10.8.1 Pfizer Basic Information
  10.8.2 Pfizer Opioids Drug Product Overview
  10.8.3 Pfizer Opioids Drug Product Market Performance
  10.8.4 Pfizer Business Overview
  10.8.5 Pfizer Recent Developments
10.9 INSYS
  10.9.1 INSYS Basic Information
  10.9.2 INSYS Opioids Drug Product Overview
  10.9.3 INSYS Opioids Drug Product Market Performance
  10.9.4 INSYS Business Overview
  10.9.5 INSYS Recent Developments
10.10 Mylan
  10.10.1 Mylan Basic Information
  10.10.2 Mylan Opioids Drug Product Overview
  10.10.3 Mylan Opioids Drug Product Market Performance
  10.10.4 Mylan Business Overview
  10.10.5 Mylan Recent Developments
10.11 Hikma
  10.11.1 Hikma Basic Information
  10.11.2 Hikma Opioids Drug Product Overview
  10.11.3 Hikma Opioids Drug Product Market Performance
  10.11.4 Hikma Business Overview
  10.11.5 Hikma Recent Developments
10.12 Egalet
  10.12.1 Egalet Basic Information
  10.12.2 Egalet Opioids Drug Product Overview
  10.12.3 Egalet Opioids Drug Product Market Performance
  10.12.4 Egalet Business Overview
  10.12.5 Egalet Recent Developments

11 OPIOIDS DRUG MARKET FORECAST BY REGION

11.1 Global Opioids Drug Market Size Forecast
11.2 Global Opioids Drug Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Opioids Drug Market Size Forecast by Country
  11.2.3 Asia Pacific Opioids Drug Market Size Forecast by Region
  11.2.4 South America Opioids Drug Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Opioids Drug by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Opioids Drug Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Opioids Drug by Type (2026-2035)
  12.1.2 Global Opioids Drug Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Opioids Drug by Type (2026-2035)
12.2 Global Opioids Drug Market Forecast by Application (2026-2035)
  12.2.1 Global Opioids Drug Sales (K MT) Forecast by Application
  12.2.2 Global Opioids Drug Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Opioids Drug Market Size by Type (M USD)
Table 4. Global Opioids Drug Market Size by Application
Table 5. Opioids Drug Market Size Comparison by Region (M USD)
Table 6. Global Opioids Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Opioids Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Opioids Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Opioids Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2025)
Table 11. Global Market Opioids Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioids Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Opioids Drug Sales by Type (K MT)
Table 27. Global Opioids Drug Market Size by Type (M USD)
Table 28. Global Opioids Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Opioids Drug Sales Market Share by Type (2020-2025)
Table 30. Global Opioids Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Opioids Drug Market Share by Type (2020-2025)
Table 32. Global Opioids Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Opioids Drug Sales (K MT) by Application
Table 34. Global Opioids Drug Market Size by Application
Table 35. Global Opioids Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Opioids Drug Sales Market Share by Application (2020-2025)
Table 37. Global Opioids Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Opioids Drug Market Share by Application (2020-2025)
Table 39. Global Opioids Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Opioids Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Opioids Drug Sales Market Share by Region (2020-2025)
Table 42. Global Opioids Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Opioids Drug Market Size by Region (2020-2025)
Table 44. North America Opioids Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Opioids Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Opioids Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Opioids Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Opioids Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Opioids Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Opioids Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Opioids Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Opioids Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Opioids Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Opioids Drug Production (K MT) by Region(2020-2025)
Table 55. Global Opioids Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Opioids Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Opioids Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Opioids Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Opioids Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Opioids Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Opioids Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Teva Basic Information
Table 63. Teva Opioids Drug Product Overview
Table 64. Teva Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Teva Business Overview
Table 66. Teva SWOT Analysis
Table 67. Teva Recent Developments
Table 68. Purdue Pharma Basic Information
Table 69. Purdue Pharma Opioids Drug Product Overview
Table 70. Purdue Pharma Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Purdue Pharma Business Overview
Table 72. Purdue Pharma SWOT Analysis
Table 73. Purdue Pharma Recent Developments
Table 74. Mallinckrodt Basic Information
Table 75. Mallinckrodt Opioids Drug Product Overview
Table 76. Mallinckrodt Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Mallinckrodt Business Overview
Table 78. Mallinckrodt SWOT Analysis
Table 79. Mallinckrodt Recent Developments
Table 80. Amneal Pharma Basic Information
Table 81. Amneal Pharma Opioids Drug Product Overview
Table 82. Amneal Pharma Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Amneal Pharma Business Overview
Table 84. Amneal Pharma Recent Developments
Table 85. Collegium Basic Information
Table 86. Collegium Opioids Drug Product Overview
Table 87. Collegium Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Collegium Business Overview
Table 89. Collegium Recent Developments
Table 90. JandJ Basic Information
Table 91. JandJ Opioids Drug Product Overview
Table 92. JandJ Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. JandJ Business Overview
Table 94. JandJ Recent Developments
Table 95. Endo Basic Information
Table 96. Endo Opioids Drug Product Overview
Table 97. Endo Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Endo Business Overview
Table 99. Endo Recent Developments
Table 100. Pfizer Basic Information
Table 101. Pfizer Opioids Drug Product Overview
Table 102. Pfizer Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Pfizer Business Overview
Table 104. Pfizer Recent Developments
Table 105. INSYS Basic Information
Table 106. INSYS Opioids Drug Product Overview
Table 107. INSYS Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. INSYS Business Overview
Table 109. INSYS Recent Developments
Table 110. Mylan Basic Information
Table 111. Mylan Opioids Drug Product Overview
Table 112. Mylan Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Mylan Business Overview
Table 114. Mylan Recent Developments
Table 115. Hikma Basic Information
Table 116. Hikma Opioids Drug Product Overview
Table 117. Hikma Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Hikma Business Overview
Table 119. Hikma Recent Developments
Table 120. Egalet Basic Information
Table 121. Egalet Opioids Drug Product Overview
Table 122. Egalet Opioids Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Egalet Business Overview
Table 124. Egalet Recent Developments
Table 125. Global Opioids Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Opioids Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Opioids Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Opioids Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Opioids Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Opioids Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Opioids Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Opioids Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Opioids Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Opioids Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Opioids Drug Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Opioids Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Opioids Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Opioids Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Opioids Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Opioids Drug Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Opioids Drug Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Opioids Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioids Drug Market Size (M USD), 2025-2035
Figure 5. Global Opioids Drug Market Size (M USD) (2020-2035)
Figure 6. Global Opioids Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioids Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Opioids Drug Product Life Cycle
Figure 13. Opioids Drug Sales Share by Manufacturers in 2025
Figure 14. Global Opioids Drug Revenue Share by Manufacturers in 2025
Figure 15. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Opioids Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Opioids Drug Revenue in 2025
Figure 18. Industry Chain Map of Opioids Drug
Figure 19. Global Opioids Drug Market PEST Analysis
Figure 20. Global Opioids Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Opioids Drug Market Share by Type
Figure 27. Sales Market Share of Opioids Drug by Type (2020-2025)
Figure 28. Sales Market Share of Opioids Drug by Type in 2025
Figure 29. Market Share of Opioids Drug by Type (2020-2025)
Figure 30. Market Share of Opioids Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Opioids Drug Market Share by Application
Figure 33. Global Opioids Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Opioids Drug Sales Market Share by Application in 2025
Figure 35. Global Opioids Drug Market Share by Application (2020-2025)
Figure 36. Global Opioids Drug Market Share by Application in 2025
Figure 37. Global Opioids Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Opioids Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Opioids Drug Market Size by Region (2020-2025)
Figure 40. North America Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Opioids Drug Sales Market Share by Country in 2024
Figure 43. North America Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Opioids Drug Market Size by Country in 2024
Figure 45. U.S. Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Opioids Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Opioids Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Opioids Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Opioids Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Opioids Drug Sales Market Share by Country in 2024
Figure 53. Europe Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Opioids Drug Market Size by Country in 2024
Figure 55. Germany Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Opioids Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Opioids Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Opioids Drug Market Size by Region in 2024
Figure 68. China Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Opioids Drug Sales and Growth Rate (K MT)
Figure 79. South America Opioids Drug Sales Market Share by Country in 2024
Figure 80. South America Opioids Drug Market Size and Growth Rate (M USD)
Figure 81. South America Opioids Drug Market Size by Country in 2024
Figure 82. Brazil Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Opioids Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Opioids Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Opioids Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Opioids Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Opioids Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Opioids Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Opioids Drug Production Market Share by Region (2020-2025)
Figure 103. North America Opioids Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Opioids Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Opioids Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Opioids Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Opioids Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Opioids Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Opioids Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Opioids Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Opioids Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Opioids Drug Market Share Forecast by Application (2026-2035)